![](https://www.worldpharmatoday.com/images/nBanners/Docuvera-728x90.jpeg")
Taiwan Vice President Hsiao Mei-chin visited the BIO Asia–Taiwan 2024 Exhibition at the Nangang Exhibition Center (TaiNEX 1) this morning (28th) to learn about the latest technologies and equipment in the biotechnology field. She affirmed Taiwan’s strong biomedical capabilities and expressed her trust that the exhibition would assist Taiwanese biotechnology companies and institutions to better connect with their international counterparts.
Upon her arrival, the Vice President presented awards to the winners of this year’s Taiwan BIO Awards in the categories “Outstanding Company of the Year,” “Emerging Company of the Year,” “Startup of the Year,” and “Innovation of the Year.” She then toured the exhibition, including the “Contract Development and Manufacturing Services,” “Precision Medicine and Genetic Testing,” “International Pavilions,” “Government and Academic Research,” and “Industry-Academia Incubation” specialty zones, to witness the full biotechnology industry chain from research and development to finished product stage, in addition to taking in some of the latest emerging technologies and equipment. She praised Taiwan’s biomedical capabilities and looked forward to the exhibition attracting and encouraging exchanges and cooperation from key biotechnology companies both domestically and internationally.
The BIO Asia–Taiwan 2024 Exhibition is held at the Taipei Nangang Exhibition Center Hall 1 (TaiNEX 1) from July 26 to July 29. This year’s theme is “Global View, Asian Touch,” showcasing the breakthrough advancements in new drugs, innovative therapies, and regenerative medicine in Asia and Taiwan amidst the region’s rapid economic development.
The event was also attended by Minister of Health and Welfare Chiu Tai-yuan, BIO Asia-Taiwan 2024 Chairman Johnsee Lee, and Taiwan Bio Industry Organization Chairman Wu Chung-hsiun, among others.
